Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

MNTS

Momentus Inc

May 06 • 04:00PM ET

0.5410

Dollar change +0.0020
Percentage change 0.37	%

Industrials • Aerospace & Defense • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Index	-	P/E	-	EPS (ttm)	-43.66	Insider Own	1.61%	Shs Outstand	13.29M	Perf Week	10.68%
Market Cap	7.19M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.19%	Shs Float	13.08M	Perf Month	24.23%
Income	-79.26M	PEG	-	EPS next Q	-	Inst Own	7.95%	Short Float	0.87%	Perf Quarter	-43.05%
Sales	2.19M	P/S	3.28	EPS this Y	-	Inst Trans	1.33%	Short Ratio	0.09	Perf Half Y	-87.15%
Book/sh	1.59	P/B	0.34	EPS next Y	-	ROA	-111.48%	Short Interest	0.11M	Perf Year	-97.36%
Cash/sh	0.76	P/C	0.71	EPS next 5Y	-	ROE	-246.98%	52W Range	0.35 - 27.32	Perf YTD	-68.73%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-836.15%	52W High	-98.02%	Beta	0.65
Dividend TTM	-	Quick Ratio	0.92	Sales past 5Y	-	Gross Margin	-	52W Low	54.57%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	0.92	EPS Y/Y TTM	5.24%	Oper. Margin	-3450.09%	RSI (14)	59.05	Volatility	10.16% 12.48%
Employees	-	Debt/Eq	2.84	Sales Y/Y TTM	1121.23%	Profit Margin	-3625.75%	Recom	1.00	Target Price	4.10
Option/Short	No / Yes	LT Debt/Eq	1.21	EPS Q/Q	44.55%	Payout	-	Rel Volume	0.17	Prev Close	0.54
Sales Surprise	-15.25%	EPS Surprise	-1.55%	Sales Q/Q	162.79%	Earnings	Nov 14 AMC	Avg Volume	1.29M	Price	0.54
SMA20	22.70%	SMA50	6.80%	SMA200	-86.61%	Trades		Volume	215,456	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-22	Initiated	Evercore ISI	Underperform	$2
Jan-10-22	Initiated	Deutsche Bank	Buy	$10

Apr-22-24 04:05PM	Momentus Receives Nasdaq Deficiency Notification Regarding Delayed Form 10-K (Business Wire) +35.69%
03:13PM	Momentus (MNTS) Stock Pops 35% Despite Nasdaq Deficiency Notice (InvestorPlace)
Apr-17-24 10:00AM	Momentus and Ascent Solar Technologies Partner to Bring to Market Leading-Edge Solar Arrays (Business Wire)
10:00AM	Momentus and Ascent Solar Technologies Partner to Bring Leading-Edge Solar Arrays to Market (GlobeNewswire)
Mar-25-24 04:30PM	Momentus Announces Chief Financial Officer Transition (Business Wire) -5.79%
12:49PM	Loading…
12:49PM	Momentus Announces Cancellation of Special Meeting of Stockholders (Business Wire)
Mar-07-24 05:05PM	Momentus Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Mar-05-24 10:07AM	MNTS Stock Alert: Momentus Snags NASA Contract (InvestorPlace)
08:14AM	Why Is Momentus (MNTS) Stock Up 11% Today? (InvestorPlace)
07:59AM	Momentus Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
07:51AM	Momentus Awarded NASA Contract to Provide Flight and Payload Integration Services (Business Wire)
Feb-01-24 08:00AM	Space Development Agency Awards Momentus Contract Modification to Develop Defense Applications for Vigoride Orbital Service Vehicle (Business Wire) -15.99%
Jan-31-24 08:00AM	Momentus Completes All Requirements of the National Security Agreement (NSA) (Business Wire) +41.86%
Jan-17-24 04:11PM	Momentus Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -6.43%
Jan-16-24 08:00AM	Momentus Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -10.82%
08:03AM	Loading…
Dec-06-23 08:03AM	Momentus Signs Contract with CalgaryToSpace for 2025 Orbital Delivery Services (Business Wire) -12.63%
Dec-05-23 08:42PM	Momentus Mission Update (Business Wire)
Nov-20-23 04:17PM	Momentus Grants Inducement Award to One New Employee (Business Wire) -10.06%
Nov-14-23 04:19PM	Momentus Inc. Announces Third Quarter 2023 Financial Results (Business Wire) +10.12%
07:33AM	Momentus Continues Testing of Sustainable Spacecraft Engine and New Type of Solar Array (Business Wire)
Nov-09-23 05:53PM	Momentus Announces Closing of Warrant Inducement Transaction for $6.5 Million in Gross Proceeds (Business Wire) -5.92%
Nov-08-23 06:30PM	Momentus and RIDE! Space Collaborate to Connect SmallSat Operators to In-Space Services (Business Wire) +5.03%
Nov-06-23 07:31AM	Momentus Signs Contract with AVS for 2024 Orbital Delivery (Business Wire) +6.28%
Nov-03-23 07:03AM	Momentus Completes Vibration Testing of Vigoride-7 Orbital Service Vehicle (Business Wire) -9.26%
Oct-30-23 02:02PM	5 Best Stocks For Day Trading (Insider Monkey) +6.13%
06:00AM	Momentus Announces Date of Third Quarter 2023 Financial Results and Conference Call (Business Wire)
Oct-23-23 08:00AM	BestGrowthStocks.Com Issues Extensive Comprehensive Analysis on Momentus Inc. (News Direct)
Oct-17-23 08:59AM	Momentus Signs Contract with SatRev for 2024 Orbital Delivery (Business Wire)
Oct-11-23 04:17PM	Momentus to Provide Delivery Service for RIDE! Space (Business Wire)
Oct-10-23 07:07AM	Momentus Customers Integrated and Shipped to SpaceX Launch Site (Business Wire) +11.87%
07:33AM	Loading…
Oct-05-23 07:33AM	Momentus Signs Contract for Orbital Delivery Services with C3S (Business Wire) +6.36%
Oct-04-23 04:36PM	Momentus Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -18.52%
Oct-02-23 02:26PM	Momentus Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -11.00%
Sep-28-23 07:39AM	Momentus Chief Executive Officer John Rood Recognized as Connectivity Business Executive to Watch (Business Wire)
Sep-19-23 07:47AM	Momentus to Provide Delivery Service for Aarhus University Payload (Business Wire)
Sep-15-23 01:04PM	Prime Movers Lab Fund I LP Sells 175,983 Shares of Momentus Inc (GuruFocus.com)
Sep-11-23 05:00PM	Momentus Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Sep-08-23 05:30PM	Momentus Regains Compliance with Nasdaq Minimum Bid Price (Business Wire) -13.47%
Sep-07-23 07:59AM	Momentus Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -12.12%
Sep-05-23 06:57PM	Momentus to Participate in Singular Research Autumn Equinox Webinar (Business Wire) -6.16%
Aug-24-23 07:53AM	Momentus to Provide Hosted Payload Services for FOSSA Systems (Business Wire) -25.26%
Aug-22-23 04:52PM	Momentus Inc. Announces Reverse Stock Split (Business Wire) -11.83%
Aug-21-23 04:25PM	Momentus Grants Inducement Awards to Four New Employees (Business Wire) -6.83%
Aug-14-23 04:25PM	Momentus Inc. Announces Second Quarter 2023 Financial Results (Business Wire) -5.60%
07:37AM	Momentus Awarded Innovation Research Contract from U.S. Defense Departments Space Development Agency (Business Wire)
Aug-02-23 08:13AM	Momentus to Highlight Low-Cost M-1000 Commercial Satellite Bus and Transportation Services at Small Satellite 2023 (Business Wire)
Jul-31-23 04:35PM	Momentus Announces Date of Second Quarter 2023 Financial Results and Conference Call (Business Wire)
Jul-28-23 07:31AM	Momentus Deploys All Payloads from Vigoride-6 Mission (Business Wire)
Jul-05-23 05:11PM	Momentus Announces Cancellation of FY 2023 Annual Meeting of Stockholders (Business Wire)
Jun-06-23 07:00AM	Presenting on the Emerging Growth Space Conference on June 7 Register to Stream (GlobeNewswire)
Jun-05-23 08:33AM	Momentus to Participate in Emerging Growth Space Conference (Business Wire) +8.62%
06:33AM	Momentus to Deliver Nine Satellites to Orbit for Apogeo Space Internet of Things Constellation (Business Wire)
Jun-01-23 04:15PM	Momentus and Axient to Collaborate on Space Services from Low-Earth Orbit to Cislunar Space (Business Wire)
May-25-23 04:24PM	Momentus to Deliver Lunasonde Technology Demonstration Payload to Orbit (Business Wire)
May-22-23 04:39PM	Momentus Grants Inducement Awards to New Employees (Business Wire)
May-18-23 08:17AM	Momentus Deploys Qosmosys Satellite and Starts Comprehensive On-Orbit Support of Caltech Hosted Payload (Business Wire)
May-12-23 09:08AM	Momentus Signs Launch Service Agreement with SpaceX (Business Wire) -8.98%
May-11-23 04:05PM	Momentus Inc. Announces First Quarter 2023 Financial Results (Business Wire)
May-09-23 07:57AM	Need a Lift? Astroscale and Momentus Team to Offer NASA a Commercial Solution to Reboost Hubble and Deliver Additional In-Space Servicing (Business Wire)
May-08-23 07:33AM	Momentus Achieves First Orbit Raise with Pioneering Propulsion System (Business Wire)
May-03-23 04:58PM	Momentus Announces Date of First Quarter 2023 Financial Results and Conference Call (Business Wire)
07:17AM	Momentus Signs Contract to Carry Hosted Payload for Hello Space (Business Wire)
Apr-24-23 08:35PM	Momentus Grants Inducement Award to New Employee (Business Wire)
Apr-17-23 04:10PM	Momentus to Bring In-Space Infrastructure Expertise to 2023 Space Symposium (Business Wire)
07:07AM	Momentus New Spacecraft Engine Continues Successful In-Space Testing (Business Wire)
Apr-15-23 06:59AM	Momentus Launches Vigoride-6 Orbital Service Vehicle on SpaceX Transporter-7 Mission (Business Wire)
Apr-05-23 07:07AM	New Chief Financial Officer Hire Strengthens Momentus Executive Leadership Team (Business Wire)
Mar-31-23 06:57AM	Momentus Pioneering Propulsion System Successfully Completes Initial Tests in Space (Business Wire) +6.36%
Mar-24-23 09:50PM	Momentus Grants Inducement Awards to 12 New Employees (Business Wire)
Mar-23-23 06:54PM	Momentus Vigoride-5 Status Update #4 (Business Wire) +10.15%
Mar-08-23 07:27AM	Momentus (NASDAQ: MNTS) Vigoride-6 Spacecraft Arrives at SpaceX Launch Site (Business Wire)
Mar-07-23 04:49PM	Momentus Inc. Announces Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-28-23 07:03AM	Momentus Announces Date of Fourth Quarter 2022 Financial Results and Conference Call (Business Wire)
Feb-23-23 09:11AM	Momentus Announces Settlement of Class Action Lawsuit (Business Wire)
08:52AM	Momentus Announces $10 Million Investment (Business Wire)
08:25AM	Momentus Provides Update on 2023 Missions (Business Wire)
Feb-22-23 05:14PM	Momentus Vigoride-5 Status Update #3 (Business Wire)
Feb-06-23 06:43PM	Momentus Vigoride-5 Status Update #2 (Business Wire) -5.61%
Feb-02-23 07:33AM	Momentus to Discuss Role of Orbital Service Vehicles in Management of Satellite Constellations (Business Wire) +12.05%
Jan-12-23 07:17AM	Momentus to Deliver FOSSA Systems Next-Generation Satellites to Orbit (Business Wire) +25.81%
Jan-09-23 07:44PM	Momentus Vigoride-5 Status Update #1 (Business Wire) +7.62%
Jan-03-23 06:32PM	Momentus Welcomes Chris Kinman as Chief Commercial Officer and Dennis Mahoney as Interim Chief Financial Officer (Business Wire) +11.41%
05:57PM	Momentus Launches Vigoride Orbital Service Vehicle on SpaceX Transporter-6 Mission (Business Wire)
Dec-30-22 04:07PM	Momentus: Celebrating a Year of Progress with More to Come in 2023 (Business Wire) -5.90%
Dec-22-22 06:00PM	Momentus Grants Inducement Awards to 10 New Employees (Business Wire)
Dec-21-22 04:20PM	John Rood Recognized as a Top 20 Dynamic CEO of 2022 (Business Wire)
Dec-20-22 07:27AM	Momentus Announces Second Services Agreement with CUAVA (Business Wire) +7.48%
Dec-05-22 07:07AM	Momentus to Fly JINJUSat-1 for CONTEC Co. (Business Wire)
Dec-02-22 05:03PM	Momentus Inc. Announces Resignation of Jikun Kim (Business Wire)
07:03AM	Momentus to Participate in Morgan Stanley Space Summit (Business Wire)
Dec-01-22 07:17AM	Momentus Vigoride Spacecraft Integrated with SpaceX Falcon 9 Launch Vehicle (Business Wire)
Nov-28-22 07:03AM	Momentus Signs Contract with Australian Research Centre to Place Satellite in Orbit (Business Wire) -10.00%
Nov-17-22 06:31AM	Momentus Vigoride Spacecraft Arrives at SpaceX Launch Site for Second Demonstration Mission (Business Wire)
Nov-11-22 10:09AM	Momentus Third Quarter 2022 Earnings: US$0.26 loss per share (vs US$0.093 loss in 3Q 2021) (Simply Wall St.) +5.22%
Nov-10-22 04:15PM	Momentus Inc. Announces Retirement of Dawn Harms (Business Wire) +8.06%
06:00AM	Momentus to Discuss In-Space Transportation at Deutsche Bank Global Space Summit (Business Wire)
Nov-08-22 04:11PM	Momentus Inc. Announces Third Quarter 2022 Financial Results (Business Wire) -9.09%
Nov-07-22 07:07AM	Momentus to Deploy Satellites in Custom Orbit for NASA LLITED Mission (Business Wire)
Nov-01-22 06:33AM	Momentus Announces Date of Third Quarter 2022 Financial Results and Conference Call (Business Wire)
Oct-31-22 04:25PM	Momentus Vigoride Orbital Service Vehicle Completes TVAC Testing Ahead of Launch with SpaceX (Business Wire) +5.80%

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHWARZ ROBERT E	Chief Technology Officer	Mar 20 '24	Option Exercise	0.00	3,311	0	3,587	Mar 22 05:16 PM
Rood John C.	Chief Executive Officer	Mar 20 '24	Option Exercise	0.00	12,844	0	18,974	Mar 22 05:17 PM
Ney Paul	Chief Legal Officer & Corp.Sec	Mar 20 '24	Option Exercise	0.00	2,789	0	4,752	Mar 22 05:16 PM
Kabot Brian	Director	Dec 01 '23	Sale	2.60	400	1,040	3,782	Dec 05 04:44 PM
Ney Paul	Chief Legal Officer & Corp.Sec	Nov 20 '23	Option Exercise	0.00	1,375	0	2,384	Nov 22 04:43 PM
Kabot Brian	Director	Nov 01 '23	Sale	3.50	400	1,400	4,182	Nov 03 04:46 PM
Kabot Brian	Director	Oct 02 '23	Sale	2.17	400	868	4,582	Oct 04 04:25 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 26 '23	Sale	1.91	17,202	32,902	60,635	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 26 '23	Sale	1.91	12,822	24,525	4,679	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 25 '23	Sale	2.04	31,261	63,913	77,837	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 25 '23	Sale	2.04	23,302	47,641	6,006	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 22 '23	Sale	2.39	13,574	32,390	109,098	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 22 '23	Sale	2.39	10,119	24,146	8,418	Sep 26 06:18 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 14 '23	Sale	3.36	81,055	272,004	122,672	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 14 '23	Sale	3.36	60,417	202,747	9,466	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 13 '23	Sale	4.51	18,637	84,099	203,727	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 13 '23	Sale	4.51	13,891	62,683	15,721	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 12 '23	Sale	5.19	1,136	5,894	222,364	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 12 '23	Sale	5.19	847	4,395	17,159	Sep 14 06:17 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 11 '23	Sale	5.57	4,526	25,208	223,500	Sep 11 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 11 '23	Sale	5.57	3,374	18,792	17,247	Sep 11 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 08 '23	Sale	5.81	6,269	36,451	228,026	Sep 11 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 08 '23	Sale	5.81	4,674	27,177	17,596	Sep 11 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 07 '23	Sale	6.51	11,748	76,450	234,295	Sep 11 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 07 '23	Sale	6.51	8,755	56,973	18,080	Sep 11 06:05 PM
Kabot Brian	Director	Sep 01 '23	Sale	10.95	400	4,381	4,982	Sep 06 05:09 PM
Rood John C.	Chief Executive Officer	Aug 18 '23	Option Exercise	0.00	229,148	0	474,744	Aug 22 04:51 PM
Mercado Victorino	Director	Aug 17 '23	Sale	0.31	33,189	10,219	93,096	Aug 18 05:11 PM
Reiners Linda J.	Director	Aug 12 '23	Option Exercise	0.00	11,111	0	126,285	Aug 15 09:57 PM
Reed Kimberly A.	Director	Aug 12 '23	Option Exercise	0.00	11,111	0	126,285	Aug 15 09:57 PM
Kabot Brian	Director	Aug 12 '23	Option Exercise	0.00	11,111	0	269,141	Aug 15 09:57 PM
Mercado Victorino	Director	Aug 12 '23	Option Exercise	0.00	11,111	0	126,285	Aug 15 09:56 PM
Hadfield Chris	Director	Aug 12 '23	Option Exercise	0.00	11,111	0	40,079	Aug 15 09:57 PM
Kabot Brian	Director	Aug 01 '23	Sale	0.42	20,000	8,410	258,030	Aug 02 05:46 PM
Prime Movers Lab Fund I LP	10% Owner	Jun 08 '23	Sale	0.27	1,822,239	484,533	12,302,114	Jun 09 04:14 PM
Prime Movers Lab Fund I LP	10% Owner	Jun 08 '23	Sale	0.27	722,301	192,060	4,876,327	Jun 09 04:14 PM
Prime Movers Lab Fund I LP	10% Owner	Jun 07 '23	Sale	0.31	1,042,308	319,884	14,124,353	Jun 09 04:14 PM
Prime Movers Lab Fund I LP	10% Owner	Jun 07 '23	Sale	0.31	413,152	126,796	5,598,628	Jun 09 04:14 PM
Kabot Brian	Director	May 30 '23	Option Exercise	0.00	86,206	0	318,030	Jun 01 09:43 PM
Reed Kimberly A.	Director	May 30 '23	Option Exercise	0.00	86,206	0	115,174	Jun 01 07:46 PM
Reiners Linda J.	Director	May 30 '23	Option Exercise	0.00	86,206	0	115,174	Jun 01 07:45 PM
Mercado Victorino	Director	May 30 '23	Option Exercise	0.00	86,206	0	115,174	Jun 01 07:45 PM
Kabot Brian	Director	May 30 '23	Sale	0.33	20,000	6,662	298,030	Jun 01 09:43 PM

Open in Screener

VAXX

Vaxxinity Inc

May 06 • 04:00PM ET

0.1300

Dollar change -0.0111
Percentage change -7.87	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF VTWO VTWG GERM

Index	RUT	P/E	-	EPS (ttm)	-0.45	Insider Own	63.81%	Shs Outstand	112.87M	Perf Week	-15.31%
Market Cap	18.29M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	50.90M	Perf Month	-80.18%
Income	-56.94M	PEG	-	EPS next Q	-	Inst Own	8.89%	Short Float	8.29%	Perf Quarter	-81.18%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	0.48%	Short Ratio	2.13	Perf Half Y	-89.34%
Book/sh	0.11	P/B	1.23	EPS next Y	-	ROA	-75.49%	Short Interest	4.22M	Perf Year	-94.09%
Cash/sh	0.22	P/C	0.60	EPS next 5Y	-	ROE	-150.65%	52W Range	0.10 - 3.10	Perf YTD	-84.71%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-41.17%	ROI	-213.47%	52W High	-95.81%	Beta	2.82
Dividend TTM	-	Quick Ratio	1.89	Sales past 5Y	-47.04%	Gross Margin	-	52W Low	30.00%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	1.89	EPS Y/Y TTM	24.63%	Oper. Margin	0.00%	RSI (14)	25.47	Volatility	20.45% 23.88%
Employees	57	Debt/Eq	1.13	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	2.00	Target Price	7.00
Option/Short	No / Yes	LT Debt/Eq	0.99	EPS Q/Q	44.61%	Payout	-	Rel Volume	2.60	Prev Close	0.14
Sales Surprise	-	EPS Surprise	10.00%	Sales Q/Q	-	Earnings	Mar 27 AMC	Avg Volume	1.98M	Price	0.13
SMA20	-60.77%	SMA50	-77.11%	SMA200	-88.25%	Trades		Volume	5,142,593	Change	-7.87%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-23	Initiated	Robert W. Baird	Outperform	$7
Apr-27-22	Initiated	Evercore ISI	In-line

May-03-24 08:24AM	Why Is Vaxxinity (VAXX) Stock Up 39% Today? (InvestorPlace) +35.41%
07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Apr-22-24 08:40AM	Why Is Vaxxinity (VAXX) Stock Down 58% Today? (InvestorPlace) -43.37%
Apr-19-24 06:53PM	Vaxxinity Issues Shareholder Letter (GlobeNewswire)
04:27PM	Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock (GlobeNewswire)
09:23AM	Loading…
Mar-28-24 09:23AM	Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
Mar-27-24 10:52PM	VAXX Stock Earnings: Vaxxinity Beats EPS for Q4 2023 (InvestorPlace) +6.00%
04:41PM	Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-07-24 10:32AM	Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD 2024 (GlobeNewswire) +9.58%
Feb-15-24 11:29AM	Vaxxinitys Heart Health Innovation to Reduce LDL Cholesterol Levels (Exec Edge) -11.09%
08:00AM	Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published (GlobeNewswire)
Feb-13-24 08:00AM	Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 (GlobeNewswire)
Jan-30-24 12:27PM	Vaxxinity, UF Join Forces Against Neurodegenerative Diseases (Exec Edge)
08:00AM	Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida (GlobeNewswire)
Jan-19-24 02:32PM	Vaxxinity & UCF to Collaborate on Space Medicine Research (Exec Edge)
08:00AM	Loading…
Jan-18-24 08:00AM	Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida (GlobeNewswire)
Jan-03-24 08:00AM	Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference (GlobeNewswire) -9.65%
Nov-20-23 06:00AM	FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success (Reuters)
Nov-13-23 06:50PM	Vaxxinity to Present at Upcoming November Medical and Investor Conferences (GlobeNewswire) +9.00%
Nov-08-23 08:30AM	Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) -9.46%
Sep-07-23 09:35AM	Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX) (Zacks)
Aug-29-23 08:00AM	Vaxxinity to Present at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-10-23 05:50PM	Vaxxinity Says UB-311 Shows Potential Advancements in Alzheimers Treatment (Exec Edge)
08:00AM	Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimers Disease (GlobeNewswire)
Aug-09-23 08:00AM	Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-28-23 10:19AM	Vaxxinity Appoints Dr. Peter Powchik as Global Scientific Director (Exec Edge) +5.09%
Jul-27-23 04:30PM	Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director (GlobeNewswire) -5.21%
Jul-17-23 12:23PM	Promising Milestone in Neurodegenerative Disease Treatment: Vaxxinitys UB-312 in Parkinsons Patients (Exec Edge) +10.50%
08:00AM	Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinsons Patients (GlobeNewswire)
Jun-22-23 01:57PM	Vaxxinity Touts Encouraging Data From Early-Stage Parkinson's Vaccine Trial (Benzinga) +8.10%
12:22PM	Loading…
12:22PM	Positive Phase 1 Results: Vaxxinitys UB-312 Shows Promise in Parkinsons Disease (Exec Edge)
08:00AM	Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinsons Disease (GlobeNewswire)
May-09-23 08:00AM	Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-03-23 06:53AM	Vaxxinity, Inc.'s (NASDAQ:VAXX) biggest owners are private companies who got richer after stock soared 23% last week (Simply Wall St.)
Apr-24-23 02:09AM	Weekly Biotech Pulse: Vaxxinity results, Biogen's FDA review, and more \| Pro Recap (Investing.com) -5.13%
Mar-28-23 08:00AM	Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April (GlobeNewswire)
Mar-27-23 07:50AM	Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-21-23 08:00AM	Vaxxinity Joins TransCelerate Research and Development Consortium (GlobeNewswire) +16.18%
Mar-20-23 08:00AM	Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia (GlobeNewswire)
Mar-02-23 08:00AM	Vaxxinity to Present at Upcoming March Scientific and Medical Conferences (GlobeNewswire)
Feb-01-23 07:40PM	Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida (GlobeNewswire)
Jan-19-23 02:04PM	Why Shares of Vaxxinity Jumped This Week (Motley Fool) +5.49%
Jan-05-23 08:00AM	Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-31-22 07:35AM	Estimating The Fair Value Of Vaxxinity, Inc. (NASDAQ:VAXX) (Simply Wall St.)
Dec-02-22 08:00AM	Vaxxinity Announces Positive Topline Pivotal Phase 3 COVID-19 Booster Data for UB-612 (GlobeNewswire) -14.29%
05:30AM	Why Shares of Vaxxinity Soared This Week (Motley Fool)
Nov-10-22 07:30AM	Vaxxinity Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-03-22 08:00AM	Vaxxinity to Host First Analyst and R&D Day in New York City on November 10, 2022 (GlobeNewswire)
Nov-01-22 09:00AM	Vaxxinity to Present at Upcoming Investor Conferences in November (GlobeNewswire) +6.06%
Oct-30-22 10:27AM	Vaxxinity, Inc. (NASDAQ:VAXX) stock most popular amongst private companies who own 48%, while individual investors hold 21% (Simply Wall St.)
Oct-24-22 08:00AM	Vaxxinity Completes Enrollment in Pivotal Phase 3 Clinical Trial of UB-612 COVID-19 Vaccine Heterologous Booster Candidate and Initiates Rolling Submission for Provisional Approval in Australia (GlobeNewswire) -6.58%
Sep-19-22 09:00AM	Multiple insiders bought Vaxxinity, Inc. (NASDAQ:VAXX) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Sep-13-22 08:00AM	Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of Migraine (GlobeNewswire)
Sep-12-22 08:00AM	Vaxxinity Initiates Rolling Submission for UB-612 COVID-19 Vaccine with MHRA (UK) (GlobeNewswire)
Sep-01-22 08:00AM	Vaxxinity to Present at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-15-22 04:39PM	UK approves COVID vaccine that targets Omicron subvariants (Yahoo Finance Video)
Aug-12-22 04:19PM	Vaxxinity CEO on COVID: The market isn't going away and it's going to be a massive commercial opportunity (Yahoo Finance)
Aug-11-22 08:00AM	Vaxxinity Reports Second Quarter 2022 Financial Results and Provides Corporate Updates (GlobeNewswire)
Aug-04-22 07:00AM	Vaxxinity to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire) +7.05%
Aug-02-22 01:43PM	Vaxxinity's Vaccine Candidate Shows Durable Cholesterol Lowering Activity In Animal Models (Benzinga) +14.58%
08:00AM	Vaxxinitys Anti-PCSK9 Candidate Demonstrates Durable LDL Cholesterol Lowering in Non-Human Primates (GlobeNewswire)
Aug-01-22 08:00AM	Vaxxinity Presents Preclinical Data on Tau Vaccine Candidates at the 2022 Alzheimer's Association International Conference (AAIC) (GlobeNewswire) +9.71%
Jul-25-22 11:57AM	Vaxxinity CEO Mei Mei Hu Speaking at White House Summit on the Future of COVID-19 Vaccines (GlobeNewswire)
Jun-02-22 07:00AM	Vaxxinity to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-12-22 09:31AM	What Percentage Of Vaxxinity, Inc. (NASDAQ:VAXX) Shares Do Insiders Own? (Simply Wall St.)
May-09-22 07:42AM	Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-05-22 07:00AM	Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference (GlobeNewswire) -17.28%
May-02-22 08:00AM	Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimers Disease (GlobeNewswire)
Apr-28-22 08:00AM	Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinsons Disease (GlobeNewswire)
Apr-12-22 08:43AM	Insiders who bought stock earlier this year lose -US$216k as Vaxxinity, Inc. (NASDAQ:VAXX) drops to US$505m (Simply Wall St.)
Apr-07-22 08:14AM	Vaxxinity Receives $9.25M Funding From CEPI To Support Pivotal COVID-19 Vaccine Trial (Benzinga)
Apr-06-22 04:43PM	CEPI to co-fund Vaxxinitys pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants (GlobeNewswire) -5.02%
Mar-28-22 08:00AM	Vaxxinity Announces First Participant Dosed in Phase 3 Study of Next-Generation COVID-19 Vaccine Booster (GlobeNewswire)
Mar-24-22 04:05PM	Vaxxinity Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-21-22 07:00AM	Vaxxinity Appoints Dr. Peter Powchik to Board of Directors (GlobeNewswire)
Feb-11-22 09:28AM	Vaxxinitys COVID-19 Vaccine Candidate UB-612 Produces High Levels of Neutralizing Antibodies Against Omicron and Other Variants of Concern (GlobeNewswire)
Jan-13-22 10:53AM	Vaxxinity (VAXX) Starts Dosing in Parkinson's Disease Study (Zacks) -9.26%
Jan-12-22 09:21AM	Vaxxinity Announces First Parkinsons Disease Patient Dosed in Part B of Phase 1 Clinical Trial of UB-312 (GlobeNewswire) +29.67%
08:10AM	Vaxxinity Shares Rise After First Patient Dosed in Parkinson's Study (Investing.com)
Jan-10-22 07:00AM	Vaxxinity Awarded Grant from The Michael J. Fox Foundation for Parkinsons Research (MJFF) to Support UB-312 Vaccine Study (GlobeNewswire)
Jan-04-22 07:00AM	Vaxxinity Appoints Jason Pesile as SVP, Finance & Accounting, and George Hornig to Board of Directors (GlobeNewswire)
Dec-23-21 04:45PM	Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates (GlobeNewswire)
Dec-07-21 07:25AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +24.45%
Nov-28-21 07:55AM	Vaxxinity Has a Rough Public Debut (Motley Fool)
Nov-18-21 04:05PM	Vaxxinity Announces Closing of IPO and Partial Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Nov-16-21 12:41PM	Vaxxinity Insider Makes $240K Stock Purchase (Benzinga) -5.19%
Nov-11-21 04:42PM	Vaxxinity, Backblaze Shares Gain in Debuts, but 3 Other IPOs Drop (Barrons.com)
01:59PM	Vaxxinity enjoys warm Wall Street reception as stock trades 20% above IPO price (MarketWatch)
06:43AM	Vaxxinity to go public with $1.6 billion valuation as downsized IPO priced below the expected range (MarketWatch)
06:30AM	Vaxxinity Announces Pricing of Initial Public Offering (GlobeNewswire)

Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer's, Parkinson's, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Prime Movers Lab Fund I LP	10% Owner	Sep 08 '23	Sale	1.67	25,089	41,899	8,713,663	Sep 08 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 08 '23	Sale	1.67	22,872	38,196	831,658	Sep 08 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 07 '23	Sale	1.79	20,312	36,302	8,738,752	Sep 08 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 07 '23	Sale	1.79	18,516	33,092	834,053	Sep 08 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 06 '23	Sale	1.88	5,308	9,991	8,759,064	Sep 08 06:05 PM
Prime Movers Lab Fund I LP	10% Owner	Sep 06 '23	Sale	1.88	4,839	9,108	835,992	Sep 08 06:05 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MNTS

Momentus Inc

VAXX

Vaxxinity Inc

Upgrade your FINVIZ experience